EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics

Simar Singh iD, Kaylin J Ellioff, Michael R Bruchas, Benjamin B Land, Nephi Stella

The Journal of Pharmacology and Experimental Therapeutics · 2024

DOI: 10.1124/jpet.124.002119 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Simar Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pharmacology (S.S., K.J.E., M.R.B., B.B.L., N.S.), Anesthesiology and Pain Medicine (M.R.B.), and Psychiatry and Behavioral Sciences (…. Hauptthemen laut MEDLINE: Endocannabinoids, Signal Transduction, Analgesics, Pain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NINDS NIH HHS, NCCIH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting the endocannabinoid (eCB) signaling system for pain relief is an important treatment option that is only now beginning to be mechanistically explored. In this review, we focus on two recently appreciated cannabinoid-based targeting strategies, treatments with cannabidiol (CBD) and α/β-hydrolase domain containing 6 (ABHD6) inhibitors, which have the exciting potential to produce pain relief through distinct mechanisms of action and without intoxication. We review evidence on plant-derived cannabinoids for pain, with an emphasis on CBD and its multiple molecular targets expressed in pain pathways. We also discuss the function of eCB signaling in regulating pain responses and the therapeutic promises of inhibitors targeting ABHD6, a 2-arachidonoylglycerol (2-AG)-hydrolyzing enzyme. Finally, we discuss how the novel cannabinoid biosensor GRABeCB2.0 may be leveraged to enable the discovery of targets modulated by cannabinoids at a circuit-specific level. SIGNIFICANCE STATEMENT: Cannabis has been used by humans as an effective medicine for millennia, including for pain management. Recent evidence emphasizes the therapeutic potential of compounds that modulate endocannabinoid signaling. Specifically, cannabidiol and inhibitors of the enzyme ABHD6 represent promising strategies to achieve pain relief by modulating endocannabinoid signaling in pain pathways via distinct, nonintoxicating mechanisms of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsSignal TransductionAnalgesicsPainHumansAnimalsMonoacylglycerol LipasesCannabidiolCannabinoidsDrug Development

Substanzen

EndocannabinoidsAnalgesicsMonoacylglycerol LipasesCannabidiolCannabinoidsABHD6 protein, human

Autor:innen und Institutionen

  • Departments of Pharmacology (S.S., K.J.E., M.R.B., B.B.L., N.S.), Anesthesiology and Pain Medicine (M.R.B.), and Psychiatry and Behavioral Sciences (N.S.), and Center of Excellence in Neuroscience of Addiction, Pain, an…

ORCID-Profile: Simar Singh

Förderung

  • NIDA NIH HHS
  • NINDS NIH HHS
  • NCCIH NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Singh, S., Ellioff, K. J., Bruchas, M. R., Land, B. B., & Stella, N. (2024). Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.124.002119

Vancouver

Singh S, Ellioff KJ, Bruchas MR, Land BB, Stella N. Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.124.002119

BibTeX
@article{Singh2024,
  author = {Singh, Simar and Ellioff, Kaylin J and Bruchas, Michael R and Land, Benjamin B and Stella, Nephi},
  title = {Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  doi = {10.1124/jpet.124.002119}
}
Kostenlos starten →